<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-052077</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Femoral nerve block for postoperative analgesia after anterior cruciate ligament reconstruction: comparison of 2 concentrations of bupivacaine with clonidine in 3 modes of administration</dc:title>
<dc:description xml:lang="en">BACKGROUND: The continuous femoral nerve block isused for postoperative orthopedic analgesia.OBJECTIVE: To evaluate 2 concentrations of bupivacainewith clonidine in 3 methods of administration forperforming a continuous femoral nerve block.MATERIAL AND METHODS: Randomized controlled trialin ASA 1-2 patients in 6 groups. In groups 1, 2, and 3, thecombination used was 0.125% bupivacaine plus clonidine.In groups 1a, 2a, and 3a, the combination was 0.0625%bupivacaine plus clonidine. Methods of administrationwere as follows: groups 1 and 1a, 10 mL·h&#150;1 in continuousinfusion; groups 2 and 2a, 5 mL·h&#150;1 in continuous infusionplus 2.5 mL e v e ry 30 minutes through a patient-controlledanalgesia (PCA) system; groups 3 and 3a, 5 mL e v e ry 30minutes in a PCA system. Pain on a visual analog scale(VAS) and amounts of bupivacaine and morphine usedwere recorded 2 and 48 hours after surgery.RESULTS: A total of 105 patients were enrolled: 17 ingroup 1, 18 in group 1a, 18 in group 2, 17 in group 2a,17 in group 3, and 18 in group 3a. No significant differencesbetween any of the 6 groups were observed forpatient characteristics, postoperative VAS scores, ormorphine use.CONCLUSIONS: A continuous femoral nerve block isuseful for managing pain after anterior cruciate ligamentsurgery. The application of 5 mL·h&#150;1 in continuousinfusion or in PCA system bolus doses provides excellentpostoperative analgesia. Use of 0.0625% bupivacained e c reases overall consumption of analgesic and is notdetrimental to quality of analgesia</dc:description>
<dc:creator>Carbonell-Bellolio, P</dc:creator>
<dc:creator>Contreras-Domínguez, V</dc:creator>
<dc:creator>Sanzana, E. S</dc:creator>
<dc:creator>Ojeda-Greciet, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">INTRODUCCIÓN: El bloqueo femoral continuo (BFC) seutiliza en la analgesia postoperatoria ortopédica.OBJETIVO: Evaluar la utilidad del BFC, comparandodos concentraciones de bupivacaína asociada a clonidina,en 3 esquemas de administración.MAT E R I A L Y MÉ TO D O: Estudio randomizado enpacientes ASA I-II divididos en seis grupos. En los 3grupos numéricos se usó bupivacaína 0,125% + clonidina.Los 3 grupos alfa-numéricos usaron bupivacaína0,0625% + clonidina. Grupo 1 y 1A: 10 mL h&#150;1 en Infusióncontinua (IC); Grupo 2 y 2A: 5 mL h&#150;1 IC + 2,5 mLc/30 min en sistema controlado por el paciente (PCRA);Grupo 3 y 3A : 5 mL c/30 min en PCRA. Se registróe n t re las 2 y 48 horas dolor postquirúrgico medianteEVA, consumo de bupivacaína y de morfina.RESULTADOS: Se incluyeron 105 pacientes: Grupo 1 (n =17), Grupo 1A(n = 18), Grupo 2 (n = 18), Grupo 2A(n = 17),Grupo 3 (n = 17), Grupo 3A (n = 18). No hubo diferenciasentre los datos demográficos, EVApostoperatorio y consumode morfina entre las 2 y 48 horas entre los seis grupos.CO N C L U S I O N E S: El BFC es útil para el manejo deldolor postoperatorio en la reconstrucción de ligamentocruzado anterior de rodilla. Un débito de 5 mL h&#150;1 en ICo en bolos PCRA asegura excelente analgesia postoperatoria.Concentraciones de bupivacaína 0,0625% disminuyeel consumo de anestésicos locales, sin detrimentoen la calidad de la analgesia</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;53(10): 626-632, dic. 2006. tab</dc:source>
<dc:identifier>ibc-052077</dc:identifier>
<dc:title xml:lang="es">Bloqueo femoral para analgesia postoperatoria en reconstrucción de ligamento cruzado anterior de rodilla. Comparación de dos concentraciones de bupivacaína asociada a clonidina en 3 modos de administración</dc:title>
<dc:subject>^d9600</dc:subject>
<dc:subject>^d34628</dc:subject>
<dc:subject>^d29646</dc:subject>
<dc:subject>^d790^s22073</dc:subject>
<dc:subject>^d23183</dc:subject>
<dc:subject>^d3025^s22000</dc:subject>
<dc:subject>^d11623</dc:subject>
<dc:subject>^d712</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d10336^s22054</dc:subject>
<dc:subject>^d28861^s22009</dc:subject>
<dc:subject>^d10336^s22057</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d2077^s22000</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d5371</dc:subject>
<dc:subject>^d790^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>200612</dc:date>
</metadata>
</record>
</ibecs-document>
